These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9860410)

  • 41. Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS).
    Jalan R; Redhead DN; Thomas HW; Henderson N; O'Rourke K; Dillon JF; Williams BC; Hayes PC
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1111-6. PubMed ID: 8944375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt.
    Wannhoff A; Hippchen T; Weiss CS; Friedrich K; Rupp C; Neumann-Haefelin C; Dollinger M; Antoni C; Stampfl U; Schemmer P; Stremmel W; Weiss KH; Radeleff B; Katus HA; Gotthardt DN
    Aliment Pharmacol Ther; 2016 May; 43(9):955-65. PubMed ID: 26919285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of celiac plexus block on splanchnic circulation--II: Changes in the systemic hemodynamics and the blood flow of the liver and kidney in dogs].
    Sekiguchi Y
    Masui; 1989 Aug; 38(8):1042-7. PubMed ID: 2810698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
    Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
    Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation.
    Mezawa S; Homma H; Ohta H; Masuko E; Doi T; Miyanishi K; Takada K; Kukitsu T; Sato T; Niitsu Y
    Am J Gastroenterol; 2001 Apr; 96(4):1155-9. PubMed ID: 11316163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
    McCormick PA; Chin J; Greenslade L; Karatapanis S; Dick R; McIntyre N; Burroughs AK
    Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
    Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
    J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laparoscopic Sugiura procedure for conditioning of the blood stream through TIPSS in cirrhotic patient. Initial experience.
    Danis J; Gruenwald M; Krieg J
    Hepatogastroenterology; 2000; 47(35):1205-7. PubMed ID: 11100312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic effects of head-down lithotomy position in patients with coronary artery disease.
    Kopman EA; Sandza JG
    Obstet Gynecol; 1979 Feb; 53(2):237-40. PubMed ID: 418980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hemodynamic evaluation during isotonic exercise of patients with orthotopic heart transplantation].
    Bocchi E; Vilas-Boas F; Bacal F; Moreira LF; Fiorelli A; Stolf N; Jatene A; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1994 Jul; 63(1):7-12. PubMed ID: 7857218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.
    Rössle M; Siegerstetter V; Olschewski M; Ochs A; Berger E; Haag K
    Am J Gastroenterol; 2001 Dec; 96(12):3379-83. PubMed ID: 11774952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure.
    Schwartz JM; Beymer C; Althaus SJ; Larson AM; Zaman A; Glickerman DJ; Kowdley KV
    J Clin Gastroenterol; 2004 Aug; 38(7):590-4. PubMed ID: 15232363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis.
    Olde Damink SW; Jalan R; Deutz NE; Redhead DN; Dejong CH; Hynd P; Jalan RA; Hayes PC; Soeters PB
    Hepatology; 2003 Jun; 37(6):1277-85. PubMed ID: 12774005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Predictive parameters of infectiologic complications in patients after TIPSS].
    Cohnen M; Lüthen R; Däubener W; Saleh A; Bode J; Häussinger D; Mödder U
    Radiologe; 2003 Feb; 43(2):155-60. PubMed ID: 12624672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.
    Stadlbauer V; Wright GA; Banaji M; Mukhopadhya A; Mookerjee RP; Moore K; Jalan R
    Gastroenterology; 2008 Jan; 134(1):111-9. PubMed ID: 18166350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis.
    Forrest EH; Stanley AJ; Redhead DN; McGilchrist AJ; Hayes PC
    Aliment Pharmacol Ther; 1996 Oct; 10(5):801-6. PubMed ID: 8899090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation.
    Lerut J; Goffette P; Laterre PF; Donataccio M; Reynaert MS; Otte JB
    Hepatogastroenterology; 1995; 42(6):985-7. PubMed ID: 8847056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [TIPSS: 10 years of clinical experience].
    Richter GM; Nöldge G; Brado M; Scharf J; Simon C; Hansmann J; Radeleff B; Kauffmann GW
    Rofo; 1998 Apr; 168(4):307-15. PubMed ID: 9589091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.